The quarter beat on sales but missed on the earnings measure that matters most. Revenue was $868 million versus published consensus of approximately $833 million, but adjusted loss per share was $0.51 versus an expected loss of $0.38. The revenue outperformance came mainly from unusually strong volumes, while profitability remained constrained by costs, freight, foreign exchange and weak zircon pricing. (Summary of Select Financial Results; Second Quarter 2026 Results)
| Metric | Q2 2026 | Comparison / expectation |
|---|---|---|
| Revenue | $868 million | $833 million published consensus; $731 million Q2 2025 (Summary of Select Financial Results) |
| Adjusted diluted loss per share | $(0.51) | $(0.38) consensus; $(0.28) Q2 2025 |
| Adjusted EBITDA | $73 million | Within prior $65–$85 million company outlook; $93 million Q2 2025 (Summary of Select Financial Results; Outlook) |
| Adjusted EBITDA margin | 8.4% | 12.7% Q2 2025 (Summary of Select Financial Results) |
| Free cash flow | $60 million | $(55) million Q2 2025; $(135) million Q1 2026 (Free Cash Flow) |
| Net leverage | 11.4x | 9.0x at December 31, 2025 (Adjusted EBITDA reconciliation) |
Volume strength is real, but it is not yet translating into durable earnings power. TiO2 revenue rose 19% year over year on an 18% volume increase, while price and mix were flat; zircon revenue rose 43% on a 61% volume increase, but zircon price and mix fell 18%. Adjusted EBITDA still declined 22% year over year to $73 million, and the margin fell 430 basis points to 8.4%. (Second Quarter 2026 Results; Summary of Select Financial Results)
Cash flow improved materially, though mainly through working-capital release rather than stronger profits. The company generated $60 million of free cash flow after reducing inventory by approximately $120 million sequentially, while first-half operating cash flow was only $37 million against $112 million of capital spending. Liquidity was $527 million, but net debt remained about $3.0 billion and trailing leverage worsened to 11.4x as EBITDA declined. (Balance Sheet, Cash Flow and Capital Allocation; Cash Flow statement; Free Cash Flow; Adjusted EBITDA reconciliation)
The outlook offers an operational rebound, but the market still needs proof that pricing can repair margins. Q3 adjusted EBITDA guidance of $95–$115 million implies a meaningful sequential improvement, supported by mid-single-digit TiO2 price increases, mid- to high-single-digit zircon price increases and the end of planned outages. However, TiO2 and zircon volumes are expected to moderate, Q3 free cash flow is expected to be roughly neutral, and elevated Middle East-related input costs remain a stated offset. With no reliable published consensus found for Q3 EBITDA, the cleanest read is that management reaffirmed the recovery path rather than delivered a new upside surprise. (Outlook)
Net read: mildly negative versus expectations. The revenue beat and positive free cash flow are constructive, but the adjusted EPS miss, sharply lower margin, deteriorating leverage and reliance on inventory liquidation outweigh the top-line upside. The filing shows improving activity, not yet a clean earnings recovery.
Read the original 8-K on SEC EDGAR ↗